SEC Form 4 · accession 0001179110-17-009254
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Akshay Vaishnaw
Director
Period of report
Jun 15, 2017
Accepted (ET)
Jun 19, 2017 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $15.63 | Jun 15, 2017 | A | 11,538 | A | — | Jun 14, 2027 | Common Stock | 11,538 | 11,538 | D |
Explanation of responses
- F1This option was granted on June 15, 2017 and is scheduled to vest in full on June 15, 2018.